10 20 30 40 50 60 70 80 1DVG - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 20-JAN-00 1DVG
TITLE CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH TITLE 2 HEME; SELELENO-METHIONINE DERIVATIVE, MUTATED AT M51T,M93L, TITLE 3 M155L,M191L.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEME OXYGENASE-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HO-1; COMPND 5 EC: 1.14.99.3; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: PLK-F; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PBACE; SOURCE 9 OTHER_DETAILS: EXPRESSED AS RESIDUES 1-267
KEYWDS ALL ALPHA, PROTEIN-SUBSTRATE COMPLEX, OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.SUGISHIMA,Y.OMATA,Y.KAKUTA,H.SAKAMOTO,M.NOGUCHI,K.FUKUYAMA
REVDAT 2 24-FEB-09 1DVG 1 VERSN REVDAT 1 12-APR-00 1DVG 0
JRNL AUTH M.SUGISHIMA,Y.OMATA,Y.KAKUTA,H.SAKAMOTO,M.NOGUCHI, JRNL AUTH 2 K.FUKUYAMA JRNL TITL CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN JRNL TITL 2 COMPLEX WITH HEME. JRNL REF FEBS LETT. V. 471 61 2000 JRNL REFN ISSN 0014-5793 JRNL PMID 10760513 JRNL DOI 10.1016/S0014-5793(00)01353-3
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 26622 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1275 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3472 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 18.70 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1DVG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JAN-00. REMARK 100 THE RCSB ID CODE IS RCSB010407.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAY-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26622 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 2.620 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.28 REMARK 200 R MERGE FOR SHELL (I) : 0.22700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, TRIS-HCL, SODIUM ACETATE, REMARK 280 CRYO:ADD GLYCEROL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.0K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.77900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 140.66850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.88950 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 GLU A 2 REMARK 465 ARG A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 LEU A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 MSE A 9 REMARK 465 GLU A 224 REMARK 465 HIS A 225 REMARK 465 LYS A 226 REMARK 465 ASP A 227 REMARK 465 GLN A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 SER A 231 REMARK 465 GLN A 232 REMARK 465 THR A 233 REMARK 465 GLU A 234 REMARK 465 PHE A 235 REMARK 465 LEU A 236 REMARK 465 ARG A 237 REMARK 465 GLN A 238 REMARK 465 ARG A 239 REMARK 465 PRO A 240 REMARK 465 ALA A 241 REMARK 465 SER A 242 REMARK 465 LEU A 243 REMARK 465 VAL A 244 REMARK 465 GLN A 245 REMARK 465 ASP A 246 REMARK 465 THR A 247 REMARK 465 THR A 248 REMARK 465 SER A 249 REMARK 465 ALA A 250 REMARK 465 GLU A 251 REMARK 465 THR A 252 REMARK 465 PRO A 253 REMARK 465 ARG A 254 REMARK 465 GLY A 255 REMARK 465 LYS A 256 REMARK 465 SER A 257 REMARK 465 GLN A 258 REMARK 465 ILE A 259 REMARK 465 SER A 260 REMARK 465 THR A 261 REMARK 465 SER A 262 REMARK 465 SER A 263 REMARK 465 SER A 264 REMARK 465 GLN A 265 REMARK 465 THR A 266 REMARK 465 PRO A 267 REMARK 465 MSE B 1 REMARK 465 GLU B 2 REMARK 465 ARG B 3 REMARK 465 PRO B 4 REMARK 465 GLN B 5 REMARK 465 LEU B 6 REMARK 465 ASP B 7 REMARK 465 SER B 8 REMARK 465 MSE B 9 REMARK 465 GLU B 224 REMARK 465 HIS B 225 REMARK 465 LYS B 226 REMARK 465 ASP B 227 REMARK 465 GLN B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 SER B 231 REMARK 465 GLN B 232 REMARK 465 THR B 233 REMARK 465 GLU B 234 REMARK 465 PHE B 235 REMARK 465 LEU B 236 REMARK 465 ARG B 237 REMARK 465 GLN B 238 REMARK 465 ARG B 239 REMARK 465 PRO B 240 REMARK 465 ALA B 241 REMARK 465 SER B 242 REMARK 465 LEU B 243 REMARK 465 VAL B 244 REMARK 465 GLN B 245 REMARK 465 ASP B 246 REMARK 465 THR B 247 REMARK 465 THR B 248 REMARK 465 SER B 249 REMARK 465 ALA B 250 REMARK 465 GLU B 251 REMARK 465 THR B 252 REMARK 465 PRO B 253 REMARK 465 ARG B 254 REMARK 465 GLY B 255 REMARK 465 LYS B 256 REMARK 465 SER B 257 REMARK 465 GLN B 258 REMARK 465 ILE B 259 REMARK 465 SER B 260 REMARK 465 THR B 261 REMARK 465 SER B 262 REMARK 465 SER B 263 REMARK 465 SER B 264 REMARK 465 GLN B 265 REMARK 465 THR B 266 REMARK 465 PRO B 267
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 74 -33.66 -136.56 REMARK 500 SER A 142 -99.34 -121.21 REMARK 500 ALA A 156 63.53 36.80 REMARK 500 THR A 222 93.76 -57.58 REMARK 500 HIS B 100 34.16 -98.12 REMARK 500 SER B 142 -95.89 -128.45 REMARK 500 THR B 222 75.24 -66.88 REMARK 500 REMARK 500 REMARK: NULL
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 25 NE2 REMARK 620 2 HOH A 373 O 174.6 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 25 NE2 REMARK 620 2 HOH B 370 O 176.1 REMARK 620 N 1
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 300 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 300
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QQ8 RELATED DB: PDB REMARK 900 HUMAN HEME OXYGENASE-1 IN COMPLEX WITH HEME REMARK 900 RELATED ID: 1DVE RELATED DB: PDB REMARK 900 RAT HEME OXYGENASE-1 IN COMPLEX WITH HEME
DBREF 1DVG A 1 267 UNP P06762 HMOX1_RAT 1 267 DBREF 1DVG B 1 267 UNP P06762 HMOX1_RAT 1 267
SEQADV 1DVG MSE A 1 UNP P06762 MET 1 MODIFIED RESIDUE SEQADV 1DVG MSE A 9 UNP P06762 MET 9 MODIFIED RESIDUE SEQADV 1DVG MSE A 34 UNP P06762 MET 34 MODIFIED RESIDUE SEQADV 1DVG THR A 51 UNP P06762 MET 51 ENGINEERED SEQADV 1DVG LEU A 93 UNP P06762 MET 93 ENGINEERED SEQADV 1DVG LEU A 155 UNP P06762 MET 155 ENGINEERED SEQADV 1DVG SER A 166 UNP P06762 PHE 166 CONFLICT SEQADV 1DVG MSE A 186 UNP P06762 MET 186 MODIFIED RESIDUE SEQADV 1DVG LEU A 191 UNP P06762 MET 191 ENGINEERED SEQADV 1DVG MSE B 1 UNP P06762 MET 1 MODIFIED RESIDUE SEQADV 1DVG MSE B 9 UNP P06762 MET 9 MODIFIED RESIDUE SEQADV 1DVG MSE B 34 UNP P06762 MET 34 MODIFIED RESIDUE SEQADV 1DVG THR B 51 UNP P06762 MET 51 ENGINEERED SEQADV 1DVG LEU B 93 UNP P06762 MET 93 ENGINEERED SEQADV 1DVG LEU B 155 UNP P06762 MET 155 ENGINEERED SEQADV 1DVG SER B 166 UNP P06762 PHE 166 CONFLICT SEQADV 1DVG MSE B 186 UNP P06762 MET 186 MODIFIED RESIDUE SEQADV 1DVG LEU B 191 UNP P06762 MET 191 ENGINEERED
SEQRES 1 A 267 MSE GLU ARG PRO GLN LEU ASP SER MSE SER GLN ASP LEU SEQRES 2 A 267 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS ILE SEQRES 3 A 267 ARG ALA GLU ASN SER GLU PHE MSE ARG ASN PHE GLN LYS SEQRES 4 A 267 GLY GLN VAL SER ARG GLU GLY PHE LYS LEU VAL THR ALA SEQRES 5 A 267 SER LEU TYR HIS ILE TYR THR ALA LEU GLU GLU GLU ILE SEQRES 6 A 267 GLU ARG ASN LYS GLN ASN PRO VAL TYR ALA PRO LEU TYR SEQRES 7 A 267 PHE PRO GLU GLU LEU HIS ARG ARG ALA ALA LEU GLU GLN SEQRES 8 A 267 ASP LEU ALA PHE TRP TYR GLY PRO HIS TRP GLN GLU ALA SEQRES 9 A 267 ILE PRO TYR THR PRO ALA THR GLN HIS TYR VAL LYS ARG SEQRES 10 A 267 LEU HIS GLU VAL GLY GLY THR HIS PRO GLU LEU LEU VAL SEQRES 11 A 267 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 A 267 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ALA SEQRES 13 A 267 LEU PRO SER SER GLY GLU GLY LEU ALA SER PHE THR PHE SEQRES 14 A 267 PRO SER ILE ASP ASN PRO THR LYS PHE LYS GLN LEU TYR SEQRES 15 A 267 ARG ALA ARG MSE ASN THR LEU GLU LEU THR PRO GLU VAL SEQRES 16 A 267 LYS HIS ARG VAL THR GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 A 267 LEU ASN ILE GLU LEU PHE GLU GLU LEU GLN ALA LEU LEU SEQRES 18 A 267 THR GLU GLU HIS LYS ASP GLN SER PRO SER GLN THR GLU SEQRES 19 A 267 PHE LEU ARG GLN ARG PRO ALA SER LEU VAL GLN ASP THR SEQRES 20 A 267 THR SER ALA GLU THR PRO ARG GLY LYS SER GLN ILE SER SEQRES 21 A 267 THR SER SER SER GLN THR PRO SEQRES 1 B 267 MSE GLU ARG PRO GLN LEU ASP SER MSE SER GLN ASP LEU SEQRES 2 B 267 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS ILE SEQRES 3 B 267 ARG ALA GLU ASN SER GLU PHE MSE ARG ASN PHE GLN LYS SEQRES 4 B 267 GLY GLN VAL SER ARG GLU GLY PHE LYS LEU VAL THR ALA SEQRES 5 B 267 SER LEU TYR HIS ILE TYR THR ALA LEU GLU GLU GLU ILE SEQRES 6 B 267 GLU ARG ASN LYS GLN ASN PRO VAL TYR ALA PRO LEU TYR SEQRES 7 B 267 PHE PRO GLU GLU LEU HIS ARG ARG ALA ALA LEU GLU GLN SEQRES 8 B 267 ASP LEU ALA PHE TRP TYR GLY PRO HIS TRP GLN GLU ALA SEQRES 9 B 267 ILE PRO TYR THR PRO ALA THR GLN HIS TYR VAL LYS ARG SEQRES 10 B 267 LEU HIS GLU VAL GLY GLY THR HIS PRO GLU LEU LEU VAL SEQRES 11 B 267 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 B 267 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ALA SEQRES 13 B 267 LEU PRO SER SER GLY GLU GLY LEU ALA SER PHE THR PHE SEQRES 14 B 267 PRO SER ILE ASP ASN PRO THR LYS PHE LYS GLN LEU TYR SEQRES 15 B 267 ARG ALA ARG MSE ASN THR LEU GLU LEU THR PRO GLU VAL SEQRES 16 B 267 LYS HIS ARG VAL THR GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 B 267 LEU ASN ILE GLU LEU PHE GLU GLU LEU GLN ALA LEU LEU SEQRES 18 B 267 THR GLU GLU HIS LYS ASP GLN SER PRO SER GLN THR GLU SEQRES 19 B 267 PHE LEU ARG GLN ARG PRO ALA SER LEU VAL GLN ASP THR SEQRES 20 B 267 THR SER ALA GLU THR PRO ARG GLY LYS SER GLN ILE SER SEQRES 21 B 267 THR SER SER SER GLN THR PRO
MODRES 1DVG MSE A 34 MET SELENOMETHIONINE MODRES 1DVG MSE A 186 MET SELENOMETHIONINE MODRES 1DVG MSE B 34 MET SELENOMETHIONINE MODRES 1DVG MSE B 186 MET SELENOMETHIONINE
HET MSE A 34 8 HET MSE A 186 8 HET MSE B 34 8 HET MSE B 186 8 HET HEM A 300 43 HET HEM B 300 43
HETNAM MSE SELENOMETHIONINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETSYN HEM HEME
FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 5 HOH *143(H2 O)
HELIX 1 1 ASP A 12 THR A 21 1 10 HELIX 2 2 THR A 21 ASN A 30 1 10 HELIX 3 3 SER A 31 LYS A 39 1 9 HELIX 4 4 SER A 43 LYS A 69 1 27 HELIX 5 5 TYR A 74 TYR A 78 5 5 HELIX 6 6 ARG A 85 GLY A 98 1 14 HELIX 7 7 HIS A 100 ILE A 105 1 6 HELIX 8 8 THR A 108 HIS A 125 1 18 HELIX 9 9 LEU A 128 LEU A 141 1 14 HELIX 10 10 SER A 142 LEU A 155 1 14 HELIX 11 11 LEU A 164 THR A 168 5 5 HELIX 12 12 ASN A 174 ASN A 187 1 14 HELIX 13 13 THR A 192 THR A 222 1 31 HELIX 14 14 ASP B 12 LYS B 22 1 11 HELIX 15 15 THR B 21 SER B 31 1 11 HELIX 16 16 SER B 31 GLY B 40 1 10 HELIX 17 17 SER B 43 LYS B 69 1 27 HELIX 18 18 TYR B 74 TYR B 78 5 5 HELIX 19 19 PHE B 79 HIS B 84 1 6 HELIX 20 20 ARG B 85 GLY B 98 1 14 HELIX 21 21 HIS B 100 ILE B 105 1 6 HELIX 22 22 THR B 108 HIS B 125 1 18 HELIX 23 23 LEU B 128 LEU B 141 1 14 HELIX 24 24 SER B 142 LEU B 155 1 14 HELIX 25 25 LEU B 164 THR B 168 5 5 HELIX 26 26 ASN B 174 ASN B 187 1 14 HELIX 27 27 THR B 192 THR B 222 1 31
LINK FE HEM A 300 NE2 HIS A 25 1555 1555 2.10 LINK FE HEM A 300 O HOH A 373 1555 1555 1.84 LINK FE HEM B 300 NE2 HIS B 25 1555 1555 2.07 LINK FE HEM B 300 O HOH B 370 1555 1555 2.03 LINK C PHE A 33 N MSE A 34 1555 1555 1.33 LINK C MSE A 34 N ARG A 35 1555 1555 1.33 LINK C ARG A 185 N MSE A 186 1555 1555 1.33 LINK C MSE A 186 N ASN A 187 1555 1555 1.33 LINK C PHE B 33 N MSE B 34 1555 1555 1.33 LINK C MSE B 34 N ARG B 35 1555 1555 1.33 LINK C ARG B 185 N MSE B 186 1555 1555 1.33 LINK C MSE B 186 N ASN B 187 1555 1555 1.33
SITE 1 AC1 17 LYS A 18 HIS A 25 GLN A 38 TYR A 134 SITE 2 AC1 17 THR A 135 GLY A 139 SER A 142 GLY A 143 SITE 3 AC1 17 LEU A 147 LYS A 179 ARG A 183 PHE A 207 SITE 4 AC1 17 ASN A 210 PHE A 214 HOH A 350 HOH A 353 SITE 5 AC1 17 HOH A 373 SITE 1 AC2 12 LYS B 18 HIS B 25 TYR B 134 THR B 135 SITE 2 AC2 12 GLY B 139 SER B 142 GLY B 143 LYS B 179 SITE 3 AC2 12 ARG B 183 PHE B 207 ASN B 210 HOH B 370
CRYST1 54.853 54.853 187.558 90.00 90.00 90.00 P 43 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018231 0.000000 0.000000 0.00000
SCALE2 0.000000 0.018231 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005332 0.00000